Trial Profile
A open-label, fixed-sequence, two-period study evaluate the effect of mavoglurant on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Mavoglurant (Primary) ; Ethinylestradiol; Levonorgestrel
- Indications Drug-induced dyskinesia; Fragile X syndrome; Obsessive-compulsive disorders
- Focus Pharmacokinetics
- 14 Oct 2015 New trial record